In active lupus nephritis, adding obinutuzumab to standard therapy increased complete renal response rates at 76 wk.
Where this comes from
- Record sourced from PubMed, PMID 40456159.
- Also identified by DOI 10.7326/ANNALS-25-01947-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Nephrology: [Formula: see text] Rheumatology: [Formula: see text].